Drug
14c Gsk961081 For Infusion
14c Gsk961081 For Infusion: highest development phase Phase 1, developed by Theravance Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| [14C]-GSK961081 solution for IV infusion NCT02663089 | Phase 1 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow 14c Gsk961081 For Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.